- Home
- QNCX vs RMI Comparison
QNCX vs RMI Comparison
Compare QNCX & RMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- RMI
- Stock Information
- Founded
- QNCX 2012
- RMI 2018
- Country
- QNCX United States
- RMI United States
- Employees
- QNCX N/A
- RMI N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- RMI Finance/Investors Services
- Sector
- QNCX Health Care
- RMI Finance
- Exchange
- QNCX Nasdaq
- RMI Nasdaq
- Market Cap
- QNCX 85.9M
- RMI 88.8M
- IPO Year
- QNCX 2019
- RMI N/A
- Fundamental
- Price
- QNCX $1.65
- RMI $14.58
- Analyst Decision
- QNCX Strong Buy
- RMI
- Analyst Count
- QNCX 6
- RMI 0
- Target Price
- QNCX $8.00
- RMI N/A
- AVG Volume (30 Days)
- QNCX 263.4K
- RMI 17.4K
- Earning Date
- QNCX 11-12-2025
- RMI 01-01-0001
- Dividend Yield
- QNCX N/A
- RMI 7.28%
- EPS Growth
- QNCX N/A
- RMI N/A
- EPS
- QNCX N/A
- RMI N/A
- Revenue
- QNCX N/A
- RMI N/A
- Revenue This Year
- QNCX N/A
- RMI N/A
- Revenue Next Year
- QNCX N/A
- RMI N/A
- P/E Ratio
- QNCX N/A
- RMI N/A
- Revenue Growth
- QNCX N/A
- RMI N/A
- 52 Week Low
- QNCX $0.69
- RMI $13.05
- 52 Week High
- QNCX $2.45
- RMI $17.37
- Technical
- Relative Strength Index (RSI)
- QNCX 56.09
- RMI 63.84
- Support Level
- QNCX $1.59
- RMI $14.49
- Resistance Level
- QNCX $1.68
- RMI $14.73
- Average True Range (ATR)
- QNCX 0.06
- RMI 0.11
- MACD
- QNCX 0.01
- RMI -0.00
- Stochastic Oscillator
- QNCX 69.57
- RMI 53.13
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About RMI RiverNorth Opportunistic Municipal Income Fund Inc.
RiverNorth Opportunistic Municipal Income Fund, Inc. is a diversified, closed-end management investment company. Its investment objective is to seek current income exempt from regular U.S. federal income taxes. The Fund's secondary investment objective is total return.